medigraphic.com
ISSN 2448-8909 (Print)

2018, Number 1

<< Back Next >>

Med Crit 2018; 32 (1)

Leuko-glycemic index and complications in patients with acute coronary syndrome

Martínez SA, Mendoza RM, López GA

Language: Spanish
References: 17
Page: 27-33
PDF size: 196.20 Kb.


ABSTRACT

Objective: To evaluate the association of the leuko-glycemic index and complications in patients with acute coronary syndrome (ACS).
Material and methods: A descriptive, cross-sectional, retrospective study was performed in 34 patients diagnosed with acute coronary syndrome, ACS: acute myocardial infarction with ST segment elevation, acute myocardial infarction without ST segment elevation and unstable angina, who entered the Intensive Care Unit from May 1, 2016 to May 31, 2017. Clinical data were recorded during the first 72 hours of the event, as well as the laboratory results, which included glycemia and leukocyte count at admission. From these data, the leukoglycemic index was calculated and its prognostic value was evaluated by the use of the χ2 test.
Results: The leuko-glycemic index was applied to the population under study and four groups were formed according to the classification obtained: grade I, 0-800 points; grade II, 801-1600 points; grade III, 1601-2400 points; and grade IV, more than 2400 points. The highest prevalence was found in group 2 (800-1601 points), with 38.24%, followed by group 4 (› 2400 points), with 35.29%. The mortality at 72 hours was 23.53%. Arrhythmias occurred in 50% of the cases.
Conclusions: There was no statistically significant correlation (p › 0.05) between the leuko-glycemic index and complications.


REFERENCES

  1. Quiroga W, Conci E, Zelaya F, Isa M, Pacheco G, Sala J, et al. Estratificación del riesgo en el infarto agudo de miocardio según el índice leucoglucémico. ¿El “Killip-Kimball” de laboratorio? Rev Fed Arg Cardiol. 2010;39(1):29-34.

  2. León AE, Pérez FG. Leucograma y glucemia en el pronóstico de pacientes con síndrome coronario agudo. Utilidad del índice leucoglucémico. Cor Salud. 2011;3(2):93-102.

  3. Thygesen K, Alpert J, Jaffe F, Maarten L. Documento de consenso de expertos. Tercera definición universal del infarto de miocardio. Rev Esp Cardiol. 2013;6(2):132.e1-e15.

  4. Martínez R. Infarto agudo de miocardio. Documento de postura, Academia Nacional de Medicina 2014. pp. 1-33.

  5. León AE, Moreno MF, Pérez FG, Vega FL, Rabassa MM. Índice leucoglucémico como marcador pronóstico de la evolución intrahospitalaria en pacientes con infarto agudo de miocardio con elevación del ST. Clin Invest Arterioscl. 2014;26(4):168-175.

  6. Santos AP, Valero HA. Factores relacionados con la evolución intrahospitalaria del síndrome coronario agudo. Revista Cubana de Cardiología. CorSalud. 2015;7(3):161-168.

  7. Lee WC, Chen HC, Fang HY, Hsueh SK, Chen CJ, Yang CH, et al. Comparison of different strategies for acute ST-segment elevation myocardial infarction with high thrombus burden in clinical practice: symptom-free outcome at one year. Heart Lung. 2015;44(6):487-493.

  8. Fernández L. Mortalidad de síndromes coronarios agudos en México. http://www.inegi.org.mx/est/contenidos/proyectos/registros/vitales/mortalidad/tabulados/PC.asp?t=14&c=11817-2015

  9. Pesaro A, Nicolau J, Serrano C, Vinicius R, Karbstein R, Giráldez R. Influencia de leucocitos y glucemia en el pronóstico de pacientes con infarto agudo de miocardio. Arq Bras Cardiol. 2009;92(2):84-89.

  10. Erkol A, Oduncu V, Turan B, Kiliçgedik A, Karabay CY, Akgün T, et al. Neutrophil to lymphocyte ratio in acute ST-segment elevation myocardial infarction. Am J Med Sci. 2014;348(1):37-42.

  11. Shah R, Berzingi C, Mumtaz M, Jasper JB, Goswami R, Morsy MS, et al. Meta-analysis comparing complete revascularization versus infarct-related only strategies for patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease. Am J Cardiol. 2016;118(10):1466-1472.

  12. Hirschson PA, Higa C, Merlo P, Domine E, Blanco E, Blanco P, et al Prognostic value of the leuko-glycemic index in acute myocardial infarction. Results from the SCAR multicenter registry. Rev Argent Cardiol. 2014;82:500-505.

  13. Martínez SC. Panorama del IAM con elevación del segmento ST en México. Rev Fed Arg Cardiol. 2013;42(3):168-169.

  14. Iaconis J, Caldas F. Valor pronóstico del índice leuco-glucémico en el stroke isquémico agudo. Asociación Médica Argentina. Curso Internacional de Investigación. Buenos Aires, Argentina, 24/10/2012.

  15. Iwakura K. Stress hyperglycemia and micro vascular obstruction after acute myocardial infarction. Journal of Cardiology. 2015;65:270-271.

  16. Jiménez M, Arguedas C, Romero L. El síndrome coronario agudo y otros diagnósticos provocan subregistro del infarto agudo de miocardio en el Hospital México, Costa Rica. Acta Médica Costarricense. 2013;55(1):24-30.

  17. Suleiman M, Hammerman H, Boulos M, Kapeliovich MR, Suleiman A, Agmon Y, et al. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation. 2005;111(6):754-760.




2020     |     www.medigraphic.com